Torren Management’s Astria Therapeutics ATXS Stock Holding History

Torren Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-77	Closed	-$1.01K	–	1031
2025 Q4	$1.01K	Buy	+77	New	+$920	﹤0.01%	1191

Torren Management's ATXS Position: Q1 2026 in Review

Torren Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 77 shares — an estimated $1.01K sold.

Torren Management first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $1.01K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Torren Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Torren Management sold 77 Astria Therapeutics shares in Q1 2026, an estimated $1.01K.
Torren Management first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Torren Management's Astria Therapeutics position peaked at $1.01K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.